BridgeBio Pharma, Inc. [BBIO] has reported $9.3 million in revenue for year ended Dec 31, 2023.
Also Read:
The company said in a filing before the Securities and Exchange Commission that its loss for the year was $653.3 million.
Also Read:
Based in Palo Alto, California, BridgeBio Pharma, Inc. operates in the Manufacturing sector.
Related Articles: